CRY

CryoLife
NYSE

Real-time Quotes | Nasdaq Last Sale

15.52
-0.74
-4.55%
After Hours: 15.81 +0.29 +1.85% 16:11 03/27 EDT
OPEN
15.77
PREV CLOSE
16.26
HIGH
16.95
LOW
15.15
VOLUME
623.32K
TURNOVER
--
52 WEEK HIGH
33.00
52 WEEK LOW
12.63
MARKET CAP
606.54M
P/E (TTM)
383.21
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CRY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CRY stock price target is 34.83 with a high estimate of 38.00 and a low estimate of 29.00.

EPS

CRY News

More
  • New CryoLife hybrid stent CE Mark'd
  • seekingalpha · 03/05 02:33
  • CryoLife Reports Receives CE Mark For E-vita Open NEO Stent Graft
  • Benzinga · 03/04 21:07
  • CryoLife Receives CE Mark for E-vita Open NEO™ Hybrid Stent Graft
  • PR Newswire · 03/04 21:05
  • Edited Transcript of CRY earnings conference call or presentation 13-Feb-20 9:30pm GMT
  • Thomson Reuters StreetEvents · 03/03 15:41

Industry

Medical Equipment, Supplies & Distribution
-1.60%
Healthcare Equipment & Supplies
-1.86%

Hot Stocks

Symbol
Price
%Change

About CRY

CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as BioGlue Surgical Adhesive, BioFoam Surgical Matrix, On-X Life Technologies Holdings, Inc. valves and surgical products, CardioGenesis cardiac laser therapy product line, PerClot and PhotoFix. PhotoFix is a pericardial patch stabilized using a dye-mediated photo-fixation process that requires no glutaraldehyde. The Preservation Services segment includes external services, such as preservation of cardiac and vascular tissues. The cardiac and vascular human tissues distributed by CryoLife include the CryoValve SG pulmonary heart valve and the CryoPatch SG pulmonary cardiac patch, both of which are processed using CryoLife's SynerGraft technology.
More

Webull offers kinds of Cryolife Inc stock information, including NYSE:CRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRY stock news, and many more online research tools to help you make informed decisions.